ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gilenya Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24K7856
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and China Gilenya Market Insights Forecast to 2027
BUY CHAPTERS

Global Gilenya Market Research Report 2025

Code: QYRE-Auto-24K7856
Report
July 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis

Gilenya Market Size

The global market for Gilenya was valued at US$ 1485 million in the year 2024 and is projected to reach a revised size of US$ 795 million by 2031, growing at a CAGR of -8.7% during the forecast period.

Gilenya Market

Gilenya Market

Gilenya is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.
The Gilenya market is primarily driven by the growing demand for effective treatments for multiple sclerosis (MS), particularly relapsing forms of the disease. Gilenya (fingolimod) is an oral medication that modulates immune system responses, aiming to reduce relapses and slow down disease progression. The increasing prevalence of MS and the need for therapies that offer convenience and improved quality of life contribute to market growth. Moreover, the shift from injectable to oral treatments and the potential to decrease relapse rates further propel adoption. However, challenges include potential cardiac effects during the initial dose and the need for monitoring patients for safety. Navigating the competitive landscape of MS treatments and addressing affordability and access barriers for a wider patient population are ongoing concerns. The market"s success hinges on continuous research to enhance safety profiles, comprehensive patient education about potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and MS patient organizations to optimize MS management while addressing the evolving challenges associated with Gilenya therapy.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gilenya, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gilenya.
The Gilenya market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gilenya market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gilenya manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gilenya Market Report

Report Metric Details
Report Name Gilenya Market
Accounted market size in year US$ 1485 million
Forecasted market size in 2031 US$ 795 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gilenya manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gilenya in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Gilenya Market size in 2031?

Ans: The Gilenya Market size in 2031 will be US$ 795 million.

Who are the main players in the Gilenya Market report?

Ans: The main players in the Gilenya Market are Novartis

What are the Application segmentation covered in the Gilenya Market report?

Ans: The Applications covered in the Gilenya Market report are Retail Pharmacy, Hospital Pharmacy, Other

What are the Type segmentation covered in the Gilenya Market report?

Ans: The Types covered in the Gilenya Market report are 28 Capsules/Box, 96 Capsules/Box

Recommended Reports

Neurological Disorders

Autoimmune Treatments

Immunology Drugs

1 Gilenya Market Overview
1.1 Product Definition
1.2 Gilenya by Type
1.2.1 Global Gilenya Market Value Comparison by Type (2024 VS 2031)
1.2.2 28 Capsules/Box
1.2.3 96 Capsules/Box
1.3 Gilenya by Application
1.3.1 Global Gilenya Market Value by Application (2024 VS 2031)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Gilenya Market Size Estimates and Forecasts
1.4.1 Global Gilenya Revenue 2020-2031
1.4.2 Global Gilenya Sales 2020-2031
1.4.3 Global Gilenya Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gilenya Market Competition by Manufacturers
2.1 Global Gilenya Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gilenya Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gilenya Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gilenya, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gilenya, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gilenya, Product Type & Application
2.7 Global Key Manufacturers of Gilenya, Date of Enter into This Industry
2.8 Global Gilenya Market Competitive Situation and Trends
2.8.1 Global Gilenya Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gilenya Players Market Share by Revenue
2.8.3 Global Gilenya Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gilenya Market Scenario by Region
3.1 Global Gilenya Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gilenya Sales by Region: 2020-2031
3.2.1 Global Gilenya Sales by Region: 2020-2025
3.2.2 Global Gilenya Sales by Region: 2026-2031
3.3 Global Gilenya Revenue by Region: 2020-2031
3.3.1 Global Gilenya Revenue by Region: 2020-2025
3.3.2 Global Gilenya Revenue by Region: 2026-2031
3.4 North America Gilenya Market Facts & Figures by Country
3.4.1 North America Gilenya Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gilenya Sales by Country (2020-2031)
3.4.3 North America Gilenya Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gilenya Market Facts & Figures by Country
3.5.1 Europe Gilenya Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gilenya Sales by Country (2020-2031)
3.5.3 Europe Gilenya Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gilenya Market Facts & Figures by Region
3.6.1 Asia Pacific Gilenya Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gilenya Sales by Region (2020-2031)
3.6.3 Asia Pacific Gilenya Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gilenya Market Facts & Figures by Country
3.7.1 Latin America Gilenya Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gilenya Sales by Country (2020-2031)
3.7.3 Latin America Gilenya Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gilenya Market Facts & Figures by Country
3.8.1 Middle East and Africa Gilenya Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gilenya Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gilenya Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gilenya Sales by Type (2020-2031)
4.1.1 Global Gilenya Sales by Type (2020-2025)
4.1.2 Global Gilenya Sales by Type (2026-2031)
4.1.3 Global Gilenya Sales Market Share by Type (2020-2031)
4.2 Global Gilenya Revenue by Type (2020-2031)
4.2.1 Global Gilenya Revenue by Type (2020-2025)
4.2.2 Global Gilenya Revenue by Type (2026-2031)
4.2.3 Global Gilenya Revenue Market Share by Type (2020-2031)
4.3 Global Gilenya Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gilenya Sales by Application (2020-2031)
5.1.1 Global Gilenya Sales by Application (2020-2025)
5.1.2 Global Gilenya Sales by Application (2026-2031)
5.1.3 Global Gilenya Sales Market Share by Application (2020-2031)
5.2 Global Gilenya Revenue by Application (2020-2031)
5.2.1 Global Gilenya Revenue by Application (2020-2025)
5.2.2 Global Gilenya Revenue by Application (2026-2031)
5.2.3 Global Gilenya Revenue Market Share by Application (2020-2031)
5.3 Global Gilenya Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Gilenya Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Gilenya Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gilenya Industry Chain Analysis
7.2 Gilenya Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gilenya Production Mode & Process Analysis
7.4 Gilenya Sales and Marketing
7.4.1 Gilenya Sales Channels
7.4.2 Gilenya Distributors
7.5 Gilenya Customer Analysis
8 Gilenya Market Dynamics
8.1 Gilenya Industry Trends
8.2 Gilenya Market Drivers
8.3 Gilenya Market Challenges
8.4 Gilenya Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
List of Tables
 Table 1. Global Gilenya Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gilenya Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gilenya Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gilenya Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Gilenya Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gilenya Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gilenya Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gilenya Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gilenya, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gilenya, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gilenya, Product Type & Application
 Table 12. Global Key Manufacturers of Gilenya, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gilenya by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gilenya as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gilenya Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gilenya Sales by Region (2020-2025) & (K Units)
 Table 18. Global Gilenya Sales Market Share by Region (2020-2025)
 Table 19. Global Gilenya Sales by Region (2026-2031) & (K Units)
 Table 20. Global Gilenya Sales Market Share by Region (2026-2031)
 Table 21. Global Gilenya Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gilenya Revenue Market Share by Region (2020-2025)
 Table 23. Global Gilenya Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gilenya Revenue Market Share by Region (2026-2031)
 Table 25. North America Gilenya Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gilenya Sales by Country (2020-2025) & (K Units)
 Table 27. North America Gilenya Sales by Country (2026-2031) & (K Units)
 Table 28. North America Gilenya Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gilenya Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gilenya Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gilenya Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Gilenya Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Gilenya Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gilenya Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gilenya Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gilenya Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Gilenya Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Gilenya Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gilenya Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gilenya Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gilenya Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Gilenya Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Gilenya Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gilenya Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gilenya Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gilenya Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Gilenya Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Gilenya Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gilenya Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gilenya Sales (K Units) by Type (2020-2025)
 Table 51. Global Gilenya Sales (K Units) by Type (2026-2031)
 Table 52. Global Gilenya Sales Market Share by Type (2020-2025)
 Table 53. Global Gilenya Sales Market Share by Type (2026-2031)
 Table 54. Global Gilenya Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gilenya Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gilenya Revenue Market Share by Type (2020-2025)
 Table 57. Global Gilenya Revenue Market Share by Type (2026-2031)
 Table 58. Global Gilenya Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Gilenya Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Gilenya Sales (K Units) by Application (2020-2025)
 Table 61. Global Gilenya Sales (K Units) by Application (2026-2031)
 Table 62. Global Gilenya Sales Market Share by Application (2020-2025)
 Table 63. Global Gilenya Sales Market Share by Application (2026-2031)
 Table 64. Global Gilenya Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gilenya Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gilenya Revenue Market Share by Application (2020-2025)
 Table 67. Global Gilenya Revenue Market Share by Application (2026-2031)
 Table 68. Global Gilenya Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Gilenya Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Gilenya Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Gilenya Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Key Raw Materials Lists
 Table 76. Raw Materials Key Suppliers Lists
 Table 77. Gilenya Distributors List
 Table 78. Gilenya Customers List
 Table 79. Gilenya Market Trends
 Table 80. Gilenya Market Drivers
 Table 81. Gilenya Market Challenges
 Table 82. Gilenya Market Restraints
 Table 83. Research Programs/Design for This Report
 Table 84. Key Data Information from Secondary Sources
 Table 85. Key Data Information from Primary Sources
 Table 86. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gilenya
 Figure 2. Global Gilenya Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gilenya Market Share by Type: 2024 & 2031
 Figure 4. 28 Capsules/Box Product Picture
 Figure 5. 96 Capsules/Box Product Picture
 Figure 6. Global Gilenya Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gilenya Market Share by Application: 2024 & 2031
 Figure 8. Retail Pharmacy
 Figure 9. Hospital Pharmacy
 Figure 10. Other
 Figure 11. Global Gilenya Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Gilenya Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Gilenya Sales (2020-2031) & (K Units)
 Figure 14. Global Gilenya Average Price (US$/Unit) & (2020-2031)
 Figure 15. Gilenya Report Years Considered
 Figure 16. Gilenya Sales Share by Manufacturers in 2024
 Figure 17. Global Gilenya Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Gilenya Players: Market Share by Revenue in Gilenya in 2024
 Figure 19. Gilenya Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Gilenya Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Gilenya Sales Market Share by Country (2020-2031)
 Figure 22. North America Gilenya Revenue Market Share by Country (2020-2031)
 Figure 23. United States Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Gilenya Sales Market Share by Country (2020-2031)
 Figure 26. Europe Gilenya Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Gilenya Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Gilenya Revenue Market Share by Region (2020-2031)
 Figure 34. China Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Gilenya Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Gilenya Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Gilenya Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Gilenya Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Gilenya Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Gilenya by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Gilenya by Type (2020-2031)
 Figure 55. Global Gilenya Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Gilenya by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Gilenya by Application (2020-2031)
 Figure 58. Global Gilenya Price (US$/Unit) by Application (2020-2031)
 Figure 59. Gilenya Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Fingolimod Hydrochloride Market Research Report 2025
Glatiramer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glatiramer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Selegiline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sphingosine 1 Phosphate Receptor S1PR Modulator Market Research Report 2024
Glatiramer Acetate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Interferon Beta 1a Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global S1P Receptor Modulator Drugs Market Research Report 2025
Multiple Sclerosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Siponimod Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fingolimod Market Research Report 2025
Remicade infliximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Avonex Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Remicade Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stelara Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Natalizumab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multiple Sclerosis Drugs Treatment Market Insights Forecast to 2030
Global Nateglinide Market Research Report 2024
Remicade Infliximab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lenalidomide Capsule Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions